January 28, 2011 | Filed under: Health,News | Posted by:
The recommendations of an FDA advisory panel could mean new restrictions on electroconvulsive therapy — a controversial treatment used by tens of thousands of U.S. patients with severe depression and other mental disorders.
Posted by
on January 28, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
Posted by
on January 28, 2011. Filed under